Christopher Mann – New Scientific and Regulatory Affairs Director

by Asphalion

3 years ago
muscular dystrophy, Christopher Mann, Biochemistry, gene therapy

Asphalion’s Board of Directors is pleased to announce the appointment of Christopher Mann as new Scientific and Regulatory Affairs Director.

WHITE PAPER | The EU Regulatory Environment of Medical Devices Software Development

by Asphalion

3 years ago
Medical Devices Software, MDSW, medical devices

New Medical Devices Software (MDSW) should be developed in Europe in accordance with the requirements of the new legislative framework given by REGULATION (EU) 2017/745 on medical devices (hereinaf...

Dominique Monferrer – New Medical Devices Director

by Asphalion

3 years ago
in vitro diagnostics, Asphalion, Dominique Monferrer, Medical Devices, technologies

Asphalion’s Board of Directors is pleased to announce the appointment of Dominique Monferrer as new Medical Devices Director.

BREXIT | Procedures for UK PIPs in case of a no-deal Brexit

by Asphalion

3 years ago
Healthcare products, Brexit, UK, Medicines

The United Kingdom (UK) has left the European Union (EU) and the transition period after Brexit comes to an end this year and from 1 January 2021 new regulations will apply. These changes will also af...

Asphalion celebrates 15,000 followers on LinkedIn!

by Asphalion

3 years ago
Regulatory Affairs, Asphalion, followers, Linkedin, Medical Devices

Today is an exciting day for Asphalion as we have reached 15,000 followers on LinkedIn!

Schedule a meeting with us!

by Asphalion

3 years ago
regulatory affairs, meeting, drug

Are you developing a drug and need help with regulatory affairs?

Today is World AIDS Day – Thanks to everyone working to end AIDS!

by Asphalion

3 years ago
HIVACAR, AIDS, HIV, health, antiretroviral therapy

Today is World AIDS Day and we would like to take this opportunity to increase the awareness on this disease and to thank everyone working tirelessly to end AIDS.

Workshop on support for orphan medicines development by EMA

by Asphalion

3 years ago
Stakeholders, orphan medicines, EMA, drugs development

Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the ...

Barcelona Innovation Day/ London 2020

by Asphalion

3 years ago
talent, Innovation Day, stakeholders, best practices, innovation

The Barcelona Innovation Day/ London 2020 is a high-level forum that will bring together the most prominent stakeholders from academia, start-ups, industry, and public institutions from Barcelona and ...

Asphalion receives medal for sustainability from EcoVadis

by Asphalion

3 years ago
Asphalion, sustainability, EcoVadis, supply chains

Asphalion is proud to announce that it has been awarded a medal for Corporate Social Responsibility from EcoVadis, the world’s most trusted provider of business sustainability ratings, intelligence,...

eSUBManager – Nueva herramienta desarrollada por Extedo

by Asphalion

4 years ago
secuencias, eSUBManager, Extedo

Asphalion presenta eSUBManager, una herramienta desarrollada por Extedo que en conexión con el eCTDManager permite, entre otras funciones:

Why is it so important to encourage people to notify adverse drug reactions?

by Asphalion

4 years ago
Pharmacovigilance, notify, drug reactions, MedSafetyWeek

Last week (2nd – 8th of November, 2020), the MedSafetyWeek was held. This initiative is a social media campaign organised by the Uppsala Monitoring Centre (UMC), the World Health Organization (WHO) ...